Acrux Limited (AU:ACR) has released an update.
Acrux Limited, a pharmaceutical company specializing in topical products, is set to present at the Hidden Gems in Life Sciences Forum, highlighting its advancements in the US market. The CEO, Michael Kotsanis, will conduct the presentation via webinar, underscoring the company’s 25 years of experience and its focus on developing affordable topical generics through strategic partnerships.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
